埋め込み型ポンプの世界市場

埋め込み型ポンプの世界市場は2030年までに247億米ドルに到達

2024年に195億米ドルと推定される埋め込み型ポンプの世界市場は、2030年には247億米ドルに達し、分析期間2024-2030年のCAGRは4.0％で成長すると予測されます。本レポートで分析したセグメントの1つである患者制御鎮痛ポンプは、CAGR 3.2%を記録し、分析期間終了時には86億米ドルに達すると予測されます。経腸ポンプ分野の成長率は、分析期間でCAGR 4.0％と推定されます。

米国市場は53億米ドルと推定、中国はCAGR 7.2％で成長予測

米国の埋め込み型ポンプ市場は2024年に53億米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 7.2%で推移し、2030年までに50億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.7%と3.1%と予測されています。欧州では、ドイツがCAGR 2.3%で成長すると予測されています。

世界の埋め込み型ポンプ市場- 主要動向と促進要因のまとめ

なぜ埋め込み型ポンプは長期ドラッグデリバリーに不可欠になりつつあるのか？

埋め込み型ポンプは、慢性疾患患者の長期連続ドラッグデリバリー用の精密制御デバイスとして脚光を浴びています。これらのシステムは外科的に植え込まれ、腔内、腹膜腔、血流などの体内区画に標的用量を直接投与するようにプログラムされます。主に疼痛管理、痙縮、化学療法、ホルモン補充療法に用いられます。体外ポンプとは異なり、埋め込み型システムは感染リスクを軽減し、患者のコンプライアンスを向上させ、全身への曝露を最小限に抑えながら安定した薬物血漿中濃度を提供します。

経口薬に反応しない重度の慢性疼痛や痙縮の患者には、低用量で局所的な治療が可能な埋め込み型ポンプによる髄腔内ドラッグデリバリーが有効です。同様に、継続的な化学療法を受けているがん患者は、標的を絞った点滴により、繰り返しの通院を避け、毒性を軽減することができます。がん、神経疾患、末期臓器疾患の世界の負担が増加するにつれ、安定的で患者に優しいドラッグデリバリー機構に対するニーズは確実に高まっています。

技術はポンプの機能性と臨床結果をどのように向上させているか？

技術の進歩により、ポンプの安全性、プログラム性、バッテリーの寿命が向上しています。最新の埋め込み型ポンプには、プログラム可能な投与、再充填可能なリザーバー、および臨床医が非侵襲的に輸液パラメータを調整できるワイヤレス遠隔測定などの機能が含まれています。低消費電力の電子機器と、薬剤の流量、リザーバーの容量、圧力の変化をリアルタイムで監視するインテリジェントなソフトウェアにより、バッテリーの寿命が延びています。これらの機能はメンテナンス頻度を減らし、長期的な臨床転帰を改善します。

ポンプ構造に使用される材料は、生体適合性を高め、感染リスクを低減するよう進化しています。新しいカテーテルデザインは、流体の安定性を向上させ、閉塞や漏れを最小限に抑えます。遠隔測定を統合したスマートポンプは、ポンプの性能を遠隔監視できるようになり、臨床医が故障を早期に発見し、必要に応じて治療を調整するのに役立っています。電子カルテ（EMR）や安全なプログラミング・プラットフォームとの統合により、データの追跡や治療のカスタマイズが効率化されています。

需要が伸びている分野と主な臨床用途は？

埋め込み型ポンプの需要は、疼痛管理、腫瘍学、内分泌学、神経学で伸びています。腰の手術に失敗した症候群やがんに関連した痛みを持つ慢性疼痛患者は、植え込み型ポンプユーザーのかなりの部分を占めています。痙縮治療、特に脳性麻痺や多発性硬化症の患者には、バクロフェン髄腔内投与ポンプがQOLの大幅な改善に役立っています。がん領域では、消化器や肝の悪性腫瘍における腹膜化学療法や局所ドラッグデリバリーでの使用が拡大しています。

市場は内分泌学分野でも拡大しており、特にホルモン補充や特定の化合物の長期注入を必要とする疾患での使用が多いです。小児科領域では一部の神経疾患での使用が増加しており、移植患者には植え込み型システムによる免疫抑制剤デリバリーが検討されています。北米と欧州での成長が最も顕著なのは、確立された償還の枠組みと専門的な外科手術の専門知識によるものであるが、アジア太平洋とラテンアメリカでは、ヘルスケア・インフラが改善するにつれて徐々に採用が増加しています。

埋め込み型ポンプ市場の成長の原動力は？

埋め込み型ポンプ市場の成長は、慢性疼痛や神経疾患の有病率の上昇、長時間持続する部位特異的な薬物送達に対する需要の増加、デバイスの信頼性と小型化の継続的な改善など、いくつかの要因によってもたらされます。生体適合材料、バッテリーシステム、プログラム可能なソフトウェアの進歩により、より安全で効率的なポンプ性能が実現しつつあります。合併症発生率の低下と患者のアドヒアランスの向上により、病院と外来の両方の医療現場で採用が進んでいます。

腫瘍センター、神経科クリニック、疼痛管理診療所などのエンドユースの拡大により、手技量が増加し、メンテナンスや再充填サービスの需要が高まっています。遠隔測定とEMRの互換性の統合は、患者の長期モニタリングと治療のカスタマイズをサポートしています。高齢化、がん罹患率の上昇、低侵襲治療オプションへの投資の増加は、市場成長にとって好条件を生み出しています。これらの開発により、埋め込み型ポンプは慢性疾患管理、精密医療、高度医療提供において不可欠なツールと位置付けられています。

セグメント

製品タイプ（患者制御鎮痛ポンプ、経腸ポンプ、インスリンポンプ、エラストマーポンプ、その他製品タイプ）、用途（腫瘍学用途、小児科/新生児学用途、消化器学用途、血液学用途、その他用途）、最終用途（病院・クリニック最終用途、外来手術センター最終用途、在宅ヘルスケア最終用途）

調査対象企業の例

• Abbott Laboratories
• AngioDynamics
• B. Braun Melsungen AG
• Baxter International Inc.
• BD（Becton, Dickinson & Co.）
• Boston Scientific Corporation
• CareFusion（now part of BD）
• Cognos Therapeutics Inc.
• Debiotech SA
• Flowonix Medical Inc.
• Fresenius Kabi AG
• Hospira（subsidiary of Pfizer）
• Insulet Corporation
• Johnson & Johnson
• Medtronic plc
• MOOG Inc.
• Smiths Medical
• Terumo Corporation
• tricumed Medizintechnik GmbH
• Zealand Pharma（affiliate in pumps）

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Implantable Pumps Market to Reach US$24.7 Billion by 2030

The global market for Implantable Pumps estimated at US$19.5 Billion in the year 2024, is expected to reach US$24.7 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Patient-Controlled Analgesia Pump, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$8.6 Billion by the end of the analysis period. Growth in the Enteral Pump segment is estimated at 4.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.3 Billion While China is Forecast to Grow at 7.2% CAGR

The Implantable Pumps market in the U.S. is estimated at US$5.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$5.0 Billion by the year 2030 trailing a CAGR of 7.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Implantable Pumps Market - Key Trends & Drivers Summarized

Why Are Implantable Pumps Becoming Integral to Long-Term Drug Delivery?

Implantable pumps are gaining prominence as precision-controlled devices for long-term, continuous drug delivery in patients with chronic conditions. These systems are surgically implanted and programmed to deliver targeted doses directly into body compartments such as the intrathecal space, peritoneal cavity, or bloodstream. They are primarily used in pain management, spasticity, chemotherapy, and hormone replacement therapy. Unlike external pumps, implantable systems reduce infection risks, improve patient compliance, and provide steady drug plasma levels with minimal systemic exposure.

Patients with severe chronic pain or spasticity who do not respond well to oral medications benefit from intrathecal drug delivery through implantable pumps, which offer localized treatment at lower doses. Similarly, cancer patients undergoing continuous chemotherapy can avoid repeated hospital visits and reduce toxicity through targeted infusion. As the global burden of cancer, neurological disorders, and end-stage organ diseases increases, the need for stable and patient-friendly drug delivery mechanisms is rising steadily.

How Is Technology Enhancing Pump Functionality and Clinical Outcomes?

Technological advancements are improving pump safety, programmability, and battery longevity. Modern implantable pumps include features such as programmable dosing, refillable reservoirs, and wireless telemetry that allow clinicians to adjust infusion parameters non-invasively. Battery life is being extended through low-power electronics and intelligent software that monitors drug flow, reservoir volume, and pressure changes in real time. These features reduce maintenance frequency and improve long-term clinical outcomes.

Materials used in pump construction are evolving to enhance biocompatibility and reduce infection risk. New catheter designs are improving fluid stability and minimizing occlusions or leakage. Smart pumps with telemetry integration are allowing remote monitoring of pump performance, helping clinicians detect malfunctions early and adjust therapy as needed. Integration with electronic medical records (EMRs) and secure programming platforms is streamlining data tracking and therapy customization.

Where Is Demand Growing, and What Are the Key Clinical Applications?

Demand for implantable pumps is growing across pain management, oncology, endocrinology, and neurology. Chronic pain patients with failed back surgery syndrome or cancer-related pain represent a significant portion of implantable pump users. In spasticity treatment, particularly for individuals with cerebral palsy or multiple sclerosis, intrathecal baclofen pumps offer substantial improvement in quality of life. Oncology use is expanding for peritoneal chemotherapy and regional drug delivery in gastrointestinal and hepatic malignancies.

The market is also expanding in endocrinology, particularly for conditions requiring hormone replacement or long-term infusion of specific compounds. Pediatric use is increasing in select neurological conditions, and transplant patients are being considered for immunosuppressive drug delivery via implantable systems. Growth is most prominent in North America and Europe due to established reimbursement frameworks and specialized surgical expertise, but adoption is gradually rising in Asia Pacific and Latin America as healthcare infrastructure improves.

What Is Driving Growth in the Implantable Pumps Market?

Growth in the implantable pumps market is driven by several factors including rising prevalence of chronic pain and neurological disorders, increased demand for long-duration, site-specific drug delivery, and continuous improvements in device reliability and miniaturization. Advancements in biocompatible materials, battery systems, and programmable software are enabling safer and more efficient pump performance. Reduced complication rates and better patient adherence are reinforcing adoption in both hospital-based and outpatient care settings.

End-use expansion across oncology centers, neurology clinics, and pain management practices is increasing procedure volumes and driving demand for maintenance and refill services. Integration of telemetry and EMR compatibility is supporting long-term patient monitoring and therapeutic customization. Aging populations, rising cancer incidence, and increased investment in minimally invasive treatment options are creating favorable conditions for market growth. These developments are positioning implantable pumps as essential tools in chronic disease management, precision medicine, and advanced care delivery.

SCOPE OF STUDY:

The report analyzes the Implantable Pumps market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump, Other Product Types); Application (Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application, Hematology Application, Other Applications); End-Use (Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use, Home Healthcare End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

• Abbott Laboratories
• AngioDynamics
• B. Braun Melsungen AG
• Baxter International Inc.
• BD (Becton, Dickinson & Co.)
• Boston Scientific Corporation
• CareFusion (now part of BD)
• Cognos Therapeutics Inc.
• Debiotech SA
• Flowonix Medical Inc.
• Fresenius Kabi AG
• Hospira (subsidiary of Pfizer)
• Insulet Corporation
• Johnson & Johnson
• Medtronic plc
• MOOG Inc.
• Smiths Medical
• Terumo Corporation
• tricumed Medizintechnik GmbH
• Zealand Pharma (affiliate in pumps)

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Implantable Pumps - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Chronic Diseases Throws the Spotlight on Implantable Pumps for Targeted Drug Delivery
  • Growing Incidence of Cancer and Severe Pain Conditions Spurs Demand for Intrathecal and Chemotherapy Infusion Systems
  • Advancements in Miniaturization and Biocompatible Materials Strengthen the Business Case for Next-Gen Implantable Pumps
  • Aging Global Population and Increasing Comorbidities Expand Addressable Market for Long-Term Drug Delivery Devices
  • Patient Preference for Reduced Hospital Visits and Home-Based Therapies Drives Adoption of Implantable Pump Solutions
  • Clinical Benefits of Continuous and Programmable Infusion Accelerate Use in Pain Management and Neurological Disorders
  • Integration with Wireless Monitoring and Smart Control Systems Enhances Safety and Treatment Precision
  • Innovation in Closed-Loop and Responsive Drug Delivery Systems Boosts Demand for Intelligent Implantable Pumps
  • Increased Use in Pediatric and Rare Disease Treatment Supports Niche Application Growth
  • Surge in Research on Biodegradable and Rechargeable Implants Fuels Development of Next-Generation Devices
  • Growing Investment in Personalized and Precision Medicine Aligns with Programmable Infusion Technologies
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Implantable Pumps Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Implantable Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Implantable Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Implantable Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Patient-Controlled Analgesia Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Patient-Controlled Analgesia Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Patient-Controlled Analgesia Pump by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Enteral Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Enteral Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Enteral Pump by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Insulin Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Insulin Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Insulin Pump by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Elastomeric Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Elastomeric Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Elastomeric Pump by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Oncology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Pediatrics / Neonatology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Pediatrics / Neonatology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Pediatrics / Neonatology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Gastroenterology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Gastroenterology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Gastroenterology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Hematology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Hematology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Hematology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Home Healthcare End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Home Healthcare End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: World 16-Year Perspective for Home Healthcare End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 44: USA Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: USA 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: USA 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: USA 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: Canada 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: Canada 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: Canada 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• JAPAN
  • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: Japan 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: Japan 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: Japan 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• CHINA
  • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 71: China Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: China 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: China 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: China 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• EUROPE
  • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Implantable Pumps by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Implantable Pumps by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: Europe 16-Year Perspective for Implantable Pumps by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: Europe 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: Europe 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: Europe 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• FRANCE
  • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 92: France Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: France 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: France 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: France 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• GERMANY
  • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Germany 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Germany 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Germany 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Italy 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: Italy 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: Italy 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 119: UK Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: UK 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: UK 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: UK 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Spain 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Spain 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Spain 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Russia 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Russia 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Russia 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Pumps by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Implantable Pumps by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 16-Year Perspective for Implantable Pumps by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Australia 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Australia 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: Australia 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• INDIA
  • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 176: India Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: India 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: India 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 182: India Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: India 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: South Korea 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: South Korea 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: South Korea 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Implantable Pumps by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Implantable Pumps by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Latin America 16-Year Perspective for Implantable Pumps by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Latin America 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Latin America 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Latin America 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Argentina 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Argentina 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Argentina 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: Brazil 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: Brazil 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: Brazil 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: Mexico 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: Mexico 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: Mexico 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Implantable Pumps by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Implantable Pumps by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Middle East 16-Year Perspective for Implantable Pumps by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Middle East 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Middle East 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Middle East 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Iran 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Iran 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Iran 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Israel 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Israel 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: Israel 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: UAE 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: UAE 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: UAE 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• AFRICA
  • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 310: Africa 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 313: Africa 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 316: Africa 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION